CVS Health Corporation is a leading health solutions company operating four segments: Health Care Benefits (Aetna), Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. It serves over 37 million members through health insurance products, operates approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics, a pharmacy benefits manager with ~87 million plan members, and offers Medicare Advantage, Medicare PDP, Medicaid, commercial medical, dental, behavioral health, and specialty pharmacy solutions.
Q2 FY2026 — expected 2026-09-22
| Name | Role | Period |
|---|---|---|
| Andrew Mok | Analyst, Barclays Capital | FY2025 – FY2025 |
| Ann Hynes | Analyst, Mizuho Securities USA LLC | FY2025 – FY2025 |
| Elizabeth Anderson | Analyst, Evercore Group LLC | FY2025 – FY2025 |
| Erin Wilson Wright | Analyst, Morgan Stanley & | FY2025 – FY2025 |
| George Hill | Analyst, Deutsche Bank Securities | FY2025 – FY2025 |
| Justin Lake | Analyst, Wolfe Research LLC | FY2025 – FY2025 |
| Lisa C. Gill | Analyst, JPMorgan Securities LLC | FY2025 – FY2025 |
| Michael Cherny | Analyst, Leerink Partners LLC | FY2025 – FY2025 |
| Edward P. DeVaney | Executive Vice President and President, Pharmacy Services, CVS Health | FY2025 – FY2025 |
| Prem S. Shah | Executive Vice President & Group Pr esident, CVS Health | FY2025 – FY2025 |
| Sreekanth K. Chaguturu | Executive Vice President and President, Health Care Delivery, CVS Health | FY2025 – FY2025 |
| Steven H. Nelson | Executive Vice President and President, Aetna | FY2025 – FY2025 |
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | CVS | discussed Healthcare & Bio | |
| topic_mention | CVS | discussed Blockchain & Crypto | |
| topic_mention | CVS | discussed Capital Expenditure | |
| topic_mention | CVS | discussed Regulation | |
| topic_mention | CVS | discussed Sovereign & Government | |
| topic_mention | CVS | discussed Enterprise | |
| topic_mention | CVS | discussed Automotive | |
| topic_mention | CVS | discussed Healthcare & Bio | |
| metric | CVS EPS | reported $1.09 | |
| metric | CVS EPS | reported $2.30 | |
| metric | CVS EPS | reported $7.00 | |
| metric | CVS EPS | reported $5.94 | |
| guidance | CVS | guided guidance of at least $9.0 billion | |
| guidance | CVS | guided expectation across 2025 and 2026 has increased by over $1.5 billion | |
| guidance | CVS | guided guidance of $3.58 billion | |
| guidance | CVS | guided guidance of at least $7.25 billion | |
| guidance | CVS | guided guidance of at least $6.09 billion | |
| topic_mention | CVS | discussed Artificial Intelligence | Q4 FY2025 |
| topic_mention | CVS | discussed Cybersecurity | Q4 FY2025 |
| topic_mention | CVS | discussed Blockchain & Crypto | Q4 FY2025 |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-10 | 2025-12-31 | 0000064803-26-000010 | EDGAR | 121K words |
| 2025-02-12 | 2024-12-31 | 0000064803-25-000007 | EDGAR | — |
| 2024-02-07 | 2023-12-31 | 0000064803-24-000007 | EDGAR | — |
| 2023-02-08 | 2022-12-31 | 0000064803-23-000009 | EDGAR | — |
| 2022-02-09 | 2021-12-31 | 0000064803-22-000008 | EDGAR | — |
| 2021-02-16 | 2020-12-31 | 0000064803-21-000011 | EDGAR | — |
| 2020-02-18 | 2019-12-31 | 0000064803-20-000007 | EDGAR | — |
| 2019-02-28 | 2018-12-31 | 0000064803-19-000013 | EDGAR | — |
| 2018-02-14 | 2017-12-31 | 0001558370-18-000707 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0000064803-26-000098 | EDGAR | — |
| 2026-05-06 | 2026-03-31 | 0000064803-26-000052 | EDGAR | — |
| 2025-10-29 | 2025-09-30 | 0000064803-25-000037 | EDGAR | 41K words |
| 2025-07-31 | 2025-06-30 | 0000064803-25-000024 | EDGAR | — |
| 2025-05-01 | 2025-03-31 | 0000064803-25-000013 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000064803-24-000034 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0000064803-24-000029 | EDGAR | — |
| 2024-05-01 | 2024-03-31 | 0000064803-24-000016 | EDGAR | — |
| 2023-11-01 | 2023-09-30 | 0000064803-23-000047 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0000064803-23-000033 | EDGAR | — |
| 2023-05-03 | 2023-03-31 | 0000064803-23-000016 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0000064803-22-000038 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0000064803-26-000097 | EDGAR | — |
| 2026-05-18 | 0000064803-26-000082 | EDGAR | — |
| 2026-05-06 | 0000064803-26-000051 | EDGAR | — |
| 2026-03-19 | 0000064803-26-000017 | EDGAR | 1K words |
| 2026-02-10 | 0000064803-26-000009 | EDGAR | — |
| 2025-12-09 | 0000064803-25-000082 | EDGAR | — |
| 2025-11-20 | 0001193125-25-289805 | EDGAR | — |
| 2025-10-29 | 0000064803-25-000036 | EDGAR | — |
| 2025-09-22 | 0001193125-25-211349 | EDGAR | — |
| 2025-08-15 | 0001193125-25-181862 | EDGAR | — |
203 total filings indexed. 172 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| Call Date | Quarter | Title |
|---|---|---|
| — | CVS Earnings Call Transcript | |
| — | Q4 FY2025 | CVS Q4 FY2025 Earnings Call Transcript |
| — | Q4 FY2025 | CVS Q4 FY2025 Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
| CIK | 0000064803 |
| Ticker | CVS |
| Exchange | NYSE |
| SIC | 5912: Retail-Drug Stores and Proprietary Stores |
| Incorporated | DE |
| Website | https://www.cvshealth.com |
| Listed | 1952-10-01 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CVS (~200 tokens, structured JSON with cryptographic provenance)